HIGHLIGHTS
- who: Lisheng Zhu from the Virginia Commonwealth University Health System, United States have published the Article: Prognostic Value of Plasma Epstein-Barr Virus DNA Levels Pre- and Post-Neoadjuvant Chemotherapy in Patients With Nasopharyngeal Carcinoma, in the Journal: (JOURNAL)
- what: This study had a few limitations.
SUMMARY
Post-treatment plasma EBV DNA levels also predicted distant metastasis and tumor recurrence; thus, additional treatment in patients with high post-treatment EBV DNA levels may prevent relapse. Among the 206 NPC patients, the plasma EBV DNA levels were evaluated before NACT (hereafter referred . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.